The relationship of testosterone and AR CAG repeat genotype with knee extensor muscle function of young and older men

Experimental Gerontology

Volumn 47, Issue 6, 2012, Pages 437-443

  Folland, J P ^a   Mc Cauley, T M ^b   Phypers, C ^a   Hanson, B ^a   Mastana, S S ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Androgen receptor; Androgens; Genetics; Muscle function; Strength

Indexed keywords

ANDROGEN RECEPTOR; CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY MASS; CAG REPEAT; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HORMONE BINDING; HUMAN; HUMAN EXPERIMENT; ISOMETRIC EXERCISE; LEAN BODY WEIGHT; MALE; MICROCHIP ELECTROPHORESIS; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TORQUE;

ADOLESCENT; ADULT; AGED; AGING; BODY COMPOSITION; HUMANS; ISOMETRIC CONTRACTION; KNEE JOINT; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; TESTOSTERONE; TRINUCLEOTIDE REPEATS; YOUNG ADULT;

EID: 84861189071     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.03.013     Document Type: Article

References (52)

1. Arden N.K., Spector T.D. Genetic influences on muscle strength, lean body mass, and bone mineral density: a twin study. J. Bone Miner. Metab. 1997, 12:2076-2081.
2. Baumgartner R.N., Waters D.L., Gallagher D., Morley J.E., Garry P.J. Predictors of skeletal muscle mass in elderly men and women. Mech. Ageing Dev. 1999, 107:123-136.
3. Brill P.A., Macera C.A., Davis D.R., Blair S.N., Gordon N. Muscular strength and physical function. Med. Sci. Sports Exerc. 2000, 32:412-416.
4. Chamberlain N.L., Driver E.D., Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994, 22:3181-3186.
5. Crabbe P., Bogaert V., De Bacquer D., Goemaere S., Zmierczak H., Kaufman J.M. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. J. Clin. Endocrinol. Metab. 2007, 92:3604-3610.
6. Dunn J.F., Nisula B.C., Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J. Clin. Endocrinol. Metabol. 1981, 53:58-68.
7. Edwards A., Hammond H.A., Jin L., Caskey C.T., Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992, 12:241-253.
8. Ekins R. Measurement of free hormones in blood. Endocr. Rev. 1990, 11:5-46.
9. Folland J.P., Williams A.G. The adaptations to strength training: morphological and neurological contributions to increased strength. Sports Med. 2007, 37:145-168.
10. Folland J.P., Hawker K., Leach B., Little T., Jones D.A. Strength training: isometric training at a range of joint angles versus dynamic training. J. Sports Sci. 2005, 23:817-824.
11. Folland J.P., Mc Cauley T.M., Williams A.G. Allometric scaling of strength measurements to body size. Eur. J. Appl. Physiol. 2008, 102:739-745.
12. Frederiksen H., Gaist D., Petersen H.C., Hjelmborg J., McGue M., Vaupel J.W., Christensen K. Hand grip strength: a phenotype suitable for identifying genetic variants affecting mid- and late-life physical functioning. Genet. Epidemiol. 2002, 23:110-122.
13. Frontera W.R., Hughes V.A., Fielding R.A., Fiatarone M.A., Evans W.J., Roubenoff R. Aging of skeletal muscle: a 12-yr longitudinal study. J. Appl. Physiol. 2000, 88:1321-1326.
14. Geirsdottir O.G., Arnarson A., Briem K., Ramel A., Tomasson K., Jonsson P.V., Thorsdottir I. Physical function predicts improvement in quality of life in elderly Icelanders after 12weeks of resistance exercise. J. Nutr. Health Aging 2012, 16:62-66.
15. Giovannucci E., Stampfer M.J., Krithivas K., Brown M., Dahl D., Brufsky A., Talcott J., Hennekens C.H., Kantoff P.W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3320-3323.
16. Guadalupe-Grau A., Rodríguez-González F.G., Ponce-González J.G., Dorado C., Olmedillas H., Fuentes T., Pérez-Gómez J., Sanchís-Moysi J., Díaz-Chico B.N., Calbet J.A. Bone mass and the CAG and GGN androgen receptor polymorphisms in young men. PLoS One 2010, 5:e11529.
17. Guadalupe-Grau A., Rodríguez-González F.G., Dorado C., Olmedillas H., Fuentes T., Pérez-Gómez J., Delgado-Guerra S., Vicente-Rodríguez G., Ara I., Guerra B., Arteaga-Ortiz R., Calbet J.A., Díaz-Chico B.N. Androgen receptor gene polymorphisms lean mass and performance in young men. Br. J. Sports Med. 2011, 45:95-100.
18. Gur H., Gransberg L., van Dyke D., Knutsson E., Larsson L. Relationship between in vivo muscle force at different speeds of isokinetic movements and myosin isoform expression. Eur. J. Appl. Physiol. 2003, 88:487-496.
19. Gutmann E., Hanzlíková V., Lojda Z. Effect of androgens on histochemical fibre type. Differentiation in the temporal muscle of the guinea pig. Histochemie 1970, 24:287-291.
20. Huhtaniemi I.T., Pye S.R., Holliday K.L., Thomson W., O'Neill T.W., Platt H., Payne D., John S.L., Jiang M., Bartfai G., Boonen S., Casanueva F.F., Finn J.D., Forti G., Giwercman A., Han T.S., Kula K., Lean M.E., Pendleton N., Punab M., Silman A.J., Vanderschueren D., Labrie F., Wu F.C. Effect of polymorphisms in selected genes involved in pituitary-testicular function on reproductive hormones and phenotype in aging men. J. Clin. Endocrinol. Metab. 2010, 95:1898-1908. EMAS Group.
21. Imagama S., Matsuyama Y., Hasegawa Y., Sakai Y., Ito Z., Ishiguro N., Hamajima N. Back muscle strength and spinal mobility are predictors of quality of life in middle-aged and elderly males. Eur. Spine J. 2011, 20:954-961.
22. Krithivas K., Yurgalevitch S.M., Mohr B.A., Wilcox C.J., Batter S.J., Brown M., Longcope C., McKinlay J.B., Kantoff P.W. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J. Endocrinol. 1999, 162:137-142.
23. Kukuvitis A., Georgiou I., Bouba I., Tsirka A., Giannouli C.H., Yapijakis C., Tarlatzis B., Bontis J., Lolis D., Sofikitis N., Papadimas J. Association of oestrogen receptor alpha polymorphisms and androgen receptor CAG trinucleotide repeats with male infertility: a study in 109 Greek infertile men. Int. J. Androl. 2002, 25:149-152.
24. Lundby C., Hellsten Y., Jensen M.B.F., Munch A.S., Pilegaard H. Erythropoietin receptor in human skeletal muscle and the effects of acute and long-term injections with recombinant human erythropoietin on the skeletal muscle. J. Appl. Physiol. 2008, 104:1154-1160.
25. Lyons G.E., Kelly A.M., Rubinstein N.A. Testosterone-induced changes in contractile protein isoforms in the sexually dimorphic temporalis muscle of the guinea pig. J. Biol. Chem. 1986, 261:13278-13284.
26. MacLean H.E., Chiu W.S., Notini A.J., Axell A.M., Davey R.A., McManus J.F., Ma C., Plant D.R., Lynch G.S., Zajac J.D. Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J. 2008, 22:2676-2689.
27. McCauley T.M., Mastana S.S., Hossack J., Macdonald M., Folland J.P. Human angiotensin-converting enzyme I/D and alpha-actinin 3 R577X genotypes and muscle functional and contractile properties. Exp. Physiol. 2009, 94:81-89.
28. McCauley T., Mastana S.S., Folland J.P. ACE I/D and ACTN3 R/X polymorphisms and muscle function and muscularity of older Caucasian men. Eur. J. Appl. Physiol. 2010, 109:269-277.
29. Meikle A.W., Stringham J.D., Bishop D.T., West D.W. Quantitating genetic and nongenetic factors influencing androgen production and clearance rates in men. J. Clin. Endocrinol. Metab. 1988, 67:104-109.
30. Mendel C.M. The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 1989, 10:232-274.
31. Mifsud A., Choon A.T., Fang D., Yong E.L. Prostate-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men. Mol. Hum. Reprod. 2001, 7:1007-1013.
32. Miller K.K., Rosner W., Lee H., Hier J., Sesmilo G., Schoenfeld D., Neubauer G., Klibanski A. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J. Clin. Endocrinol. Metab. 2004, 89:525-533.
33. Mitsumori K., Terai A., Oka H., Segawa T., Ogura K., Yoshida O., Ogawa O. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth. Prostate 1999, 41:253-257.
34. Nelson N.R., Bird I.M., Behan M. Testosterone restores respiratory long term facilitation in old male rats by an aromatase-dependent mechanism. J. Physiol. 2011, 589:409-421.
35. Nielsen T.L., Hagen C., Wraae K., Bathum L., Larsen R., Brixen K., Andersen M. The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study. Eur. J. Endocrinol. 2010, 162:795-804.
36. O'Connell M.D., Tajar A., Roberts S.A., Wu F.C. Do androgens play any role in the physical frailty of ageing men?. Int. J. Androl. 2011, 34:195-211.
37. O'Donnell A.B., Travison T.G., Harris S.S., Tenover J.L., McKinlay J.B. Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 2006, 91:425-431.
38. Ophoff J., Van Proeyen K., Callewaert F., De Gendt K., De Bock K., Vanden Bosch A., Verhoeven G., Hespel P., Vanderschueren D. Androgen signaling in myocytes contributes to the maintenance of muscle mass and fiber type regulation but not to muscle strength or fatigue. Endocrinology 2009, 150:3558-3566.
39. Overend T.J., Cunningham D.A., Kramer J.F., Lefcoe M.S., Paterson D.H. Knee extensor and knee flexor strength: cross-sectional area ratios in young and elderly men. J. Gerontol. 1992, 47:M204-M210.
40. Pardridge W.M. Selective delivery of sex steroid hormones to tissues by albumin and by sex hormone-binding globulin. Oxf. Rev. Reprod. Biol. 1988, 10:237-292.
41. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J. Clin. Endocrinol. Metab. 2007, 92:405-413.
42. Roy T.A., Blackman M.R., Harman S.M., Tobin J.D., Schrager M., Metter E.J. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E284-E294.
43. Sallinen J., Stenholm S., Rantanen T., Heliövaara M., Sainio P., Koskinen S. Hand-grip strength cut points to screen older persons at risk for mobility limitation. J. Am. Geriatr. Soc. 2010, 58:1721-1726.
44. Simon D., Nahoul K., Charles M.A. Sex hormones, aging, ethnicity and insulin sensitivity in men: an overview of the TELECOM study. Androgens and the Ageing Male 1996, Parthenon Publishing, New York. A. Vermeulen, B.J. Odens (Eds.).
45. Staron R.S., Hagerman F.C., Hikida R.S., Murray T.F., Hostler D.P., Crill M.T., Ragg K.E., Toma K. Fiber type composition of the vastus lateralis muscle of young men and women. J. Histochem. Cytochem. 2000, 48:623-629.
46. Stenholm S., Tiainen K., Rantanen T., Sainio P., Heliövaara M., Impivaara O., Koskinen S. Long-term determinants of muscle strength decline: prospective evidence from the 22-year mini-Finland follow-up survey. J. Am. Geriatr. Soc. 2012, 60:77-85.
47. van den Beld A.W., de Jong F.H., Grobbee D.E., Pols H.A., Lamberts S.W. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J. Clin. Endocrinol. Metab. 2000, 85:3276-3282.
48. Van Pottelbergh I., Lumbroso S., Goemaere S., Sultan C., Kaufman J.M. Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men. Clin. Endocrinol. 2001, 55:659-666.
49. Vermeulen A. Declining androgens with age: an overview. Androgens and the ageing male 1996, Parthenon Publishing, New York. A. Vermeulen, B.J. Odens (Eds.).
50. Vermeulen A., Verdonck L., Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 1999, 84:3666-3672.
51. Vingren J.L., Kraemer W.J., Ratamess N.A., Anderson J.M., Volek J.S., Maresh C.M. Testosterone physiology in resistance exercise and training: the up-stream regulatory elements. Sports Med. 2010, 40:1037-1053.
52. Walsh S., Zmuda J.M., Cauley J.A., Shea P.R., Metter E.J., Hurley B.F., Ferrell R.E., Roth S.M. Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. J. Appl. Physiol. 2005, 98:132-137.